Results 251 to 260 of about 227,486 (302)
Pharmacokinetic variability of vancomycin in patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study in Peru. [PDF]
Ther Adv Drug SafBolaños-Vargas W +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Pediatric Hematopoietic Stem Cell Transplant
Pediatrics In Review, 20201. Ellen Fraint, MD* 2. Mary Jo Holuba, MSN, CPNP* 3. Lisa Wray, MD† 1. *Division of Pediatric Hematology, Oncology, and Cellular Therapy, Children’s Hospital at Montefiore, Bronx, NY 2. †Division of Oncology, Children’s Hospital of Philadelphia, and Department of Pediatrics, University of Pennsylvania Perelman School of Medicine ...
Ellen, Fraint +2 more
openaire +2 more sources
Hematopoietic Stem Cell Transplantation
Hospital Practice, 1993The isolation, purification, and in vitro expansion of the hematopoietic stem cell have allowed pretransplant immunologic and genetic manipulation. As a result, rapid allogeneic or autologous hematologic reconstitution with minimal graft-versus-host disease is possible in patients receiving high-dose chemotherapy.
S, Jagannath, B, Barlogie, G, Tricot
openaire +2 more sources
Hematopoietic Stem-Cell Transplantation
New England Journal of Medicine, 2006Hematopoietic stem-cell transplantation, which is used to treat both malignant and nonmalignant conditions, was first conceived more than 50 years ago, but problems associated with transplanting a nonsolid organ and modulating the immune response had to be solved before the procedure could be used clinically.
openaire +3 more sources
Spousal hematopoietic stem cell transplantation
International Journal of Hematology, 2016We report a pilot series of five patients who received stem cell transplantation (SCT) from a spouse for post-transplant relapse or rejection. The inclusion criterion regarding HLA disparities was three or fewer antigen mismatches in the graft-versus-host direction at the HLA-A, B, and DR loci.
Kazuhiro, Ikegame +12 more
openaire +2 more sources
Fetal hematopoietic stem cell transplantation
Seminars in Perinatology, 1999In utero hematopoietic stem cell transplantation (IUHSCTx) is a promising approach for the treatment of a potentially large number of fetuses affected by congenital hematologic disorders. With technical and molecular advances in prenatal diagnosis, the majority of these diseases can now be diagnosed early in gestation, allowing consideration of ...
A F, Shaaban, A W, Flake
openaire +2 more sources
PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Hematology/Oncology Clinics of North America, 2001The successful use of allogeneic HSCT for children with malignant and nonmalignant diseases continues to be limited by the development of acute and chronic GVHD, infectious complications, delayed recovery of the immune system, acute and long-term toxicity, and relapse of disease.
T G, Gross, R M, Egeler, F O, Smith
openaire +2 more sources
Allogeneic Hematopoietic Stem Cell Transplantation
Therapeutic Apheresis and Dialysis, 2003Abstract: More than 30 years have passed since the first clinical application of allogeneic bone marrow transplantation to treat hematological diseases. In recent years, the availability of peripheral blood and cord blood as additional sources of stem cells other than bone marrow has expanded the applicability of hematopoietic stem cell transplantation.
Shunro, Kai, Hiroshi, Hara
openaire +2 more sources
Mouse Hematopoietic Stem Cell Transplantation
2013Hematopoietic stem cells (HSCs) are capable of self-renewal and multi-lineage reconstitution of hematopoiesis in irradiated transplant recipient mice. As such, bone marrow transplantation (BMT) is a major assay commonly used to examine murine HSC activity.
Hui, Cheng, Paulina H, Liang, Tao, Cheng
openaire +2 more sources